by Jordana Choucair | Sep 16, 2022 | Life Sciences
A New York Times article provides insight into the Food and Drug Administration (FDA) prescription drug user fee debate as Congress works toward finalizing a bill by September 30. While critics of the program say it gives the drug and medical device industry too much...
by Jordana Choucair | Sep 16, 2022 | Providers
The Centers for Medicare & Medicaid Services (CMS) released preliminary data revealing that 25 percent of hospitals will not face penalties under its Hospital Readmissions Reduction Program. Additionally, 57 percent fewer hospitals will pay penalties exceeding 1...
by Jordana Choucair | Sep 16, 2022 | Providers
Representative Bill Pascrell, chair of the House Ways and Means Committee’s Subcommittee on Oversight, called on the U.S. Department of Health and Human Services (HHS) to investigate “disturbing questions about HCA’s corporate policies and practices.” Earlier this...
by Jordana Choucair | Sep 16, 2022 | Providers
The House Ways and Means Committee released a report that found that extreme weather such as fires, flooding and heat waves, events that have resulted in compromised medical services and facility closures. Most of the 63 hospital systems and community health centers...
by Jordana Choucair | Sep 15, 2022 | Life Sciences
The White House is planning to allocate $2 billion to launch President Biden’s new national biomanufacturing initiative. According to a press release, the administration will invest $1.7 billion to expand domestic biomanufacturing: the Department of Defense (DoD) will...
Recent Comments